Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
Clinical trial NCT02646800 · TERMINATED
Trial details
- NCT number
- NCT02646800
- Sponsor
- Astellas Pharma China, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-21
- Primary completion
- 2014-12-21
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.